Ronald Aldridge
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Ronald Aldridge
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Holding Company | Miscellaneous Commercial Services | 16 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ronald Aldridge tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Boston Millennia Partners
Boston Millennia Partners Investment ManagersFinance Boston Millennia Partners (BMP) is a private equity and venture capital subsidiary of Glen Ventures Management, Inc founded in 1997 by Dana Callow. The firm headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member | |
Pamplona Capital Management LLP
Pamplona Capital Management LLP Investment ManagersFinance Pamplona Capital Management LLP (Pamplona Capital Management) is a private equity firm founded in 2005 by Alexander Mark Knaster. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
HAEMONETICS CORPORATION | Medical Specialties | Director of Finance/CFO Chairman | |
Boston Millennia Partners III LP
Boston Millennia Partners III LP Investment ManagersFinance Boston Millennia Partners III LP invests in both public and private companies located in the US and Canada, primarily in the Eastern United States. The fund focuses on companies with strong management teams, sustainable competitive advantage and growth potential. It targets companies operating in the fields of healthcare IT, business services and life sciences. It acts as a lead investor and provides financing for growth & later stage capital requirements with an investment size of $3 - $10 million. It invests as low as $1 million and up to $15 million in the portfolio company. It makes co-investments, seeks a seat on the board of directors and also makes follow on investments. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Tufts University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
University of Virginia Darden School of Business | College/University | Masters Business Admin | |
Novitas Loans Ltd.
Novitas Loans Ltd. Finance/Rental/LeasingFinance Novitas Loans Ltd. provides loans and legal services. It solves the cash-flow challenge in two distinct ways; by providing loans to clients purchasing specific legal services, or through a tailored loan facility to the actual law firm. The company was founded in 2011 and is headquartered in Salisbury, the United Kingdom. | Finance/Rental/Leasing | Director/Board Member | |
CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Director/Board Member | |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
AVON PRODUCTS, INC. | Household/Personal Care | Comptroller/Controller/Auditor | |
EDITAS MEDICINE, INC. | Biotechnology | Chairman | |
AADI BIOSCIENCE, INC. | Biotechnology | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Biotechnology | Director/Board Member | |
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Imperial College London | College/University | Undergraduate Degree | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Institute For Protein Innovation, Inc.
Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
FIBROGEN, INC. | Pharmaceuticals: Major | Director/Board Member | |
GRAIL LLC
GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Medical Specialties | Director/Board Member | |
Parexel International Corp. Ltd.
Parexel International Corp. Ltd. Financial ConglomeratesFinance Parexel International Corp. Ltd. functions as an investment holding British company. The private company is based in Basingstoke, UK. | Financial Conglomerates | Director/Board Member | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
Qiming Venture Partners Ltd.
Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Investment Managers | Private Equity Investor | |
NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Dupont De Nemours & Co., Inc.
Dupont De Nemours & Co., Inc. Agricultural Commodities/MillingProcess Industries Part of Corteva, Inc., Dupont De Nemours & Co., Inc. is a company that manufactures hybrid corn and soybean seeds. The company is based in Wilmington, DE. | Agricultural Commodities/Milling | Sales & Marketing | |
NOVIMMUNE SA | Medical/Nursing Services | Chairman | |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Director/Board Member | |
University of Basel | College/University | Doctorate Degree | |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
TIGENIX NV | Medical Specialties | Director/Board Member | |
University of Zurich | College/University | Doctorate Degree | |
Swiss Cancer Foundation | Director/Board Member | ||
Philips Healthcare
Philips Healthcare Medical SpecialtiesHealth Technology Philips Healthcare engages in the manufacture of electromedical apparatus. It develops products that offer added value to the entire care cycle: from disease prevention to screening, diagnosis, treatment and follow-up care at home or in hospital. It also deals with cardiology, oncology, and women's health. It focuses on serious health problems, which people are confronted, such as heart problems, lung and breast disease. The company is headquartered in Eindhoven, the Netherlands. | Medical Specialties | Director of Finance/CFO |
Statistiche
Distribuzione geografica
Stati Uniti | 28 |
Regno Unito | 10 |
Svizzera | 9 |
India | 2 |
Francia | 2 |
Settori
Health Technology | 29 |
Finance | 9 |
Consumer Services | 6 |
Commercial Services | 4 |
Health Services | 3 |
Posizioni
Director/Board Member | 99 |
Corporate Officer/Principal | 39 |
Independent Dir/Board Member | 27 |
Director of Finance/CFO | 25 |
Chairman | 16 |
Contatti più connessi
Insiders | |
---|---|
Ellen Zane | 32 |
Patrick J. Fortune | 24 |
Richard L. Love | 23 |
A. Callow | 18 |
Emma Reeve | 18 |
May Kin Ho | 16 |
Ingo Bank | 14 |
Jeremy Gelber | 13 |
Eduard Enrico Holdener | 11 |
Amol Chaubal | 11 |
Chris Lindop | 9 |
Simon Harford | 9 |
Andrew Singer | 9 |
John Doyle | 7 |
Mark Stephenson | 1 |
- Borsa valori
- Insiders
- Ronald Aldridge
- Connessioni Società